Non-muscle invasive bladder neoplasms
Clinical trials for Non-muscle invasive bladder neoplasms explained in plain language.
Never miss a new study
Get alerted when new Non-muscle invasive bladder neoplasms trials appear
Sign up with your email to follow new studies for Non-muscle invasive bladder neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder cancer device could delay return of tumors without removing bladder
Disease control OngoingThis study tests a new treatment called TAR-200 for people with a high-risk type of bladder cancer that came back after standard therapy (BCG). Participants either receive TAR-200 or standard chemotherapy placed directly into the bladder. The goal is to see if TAR-200 can keep th…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New bladder cancer treatment delivers drug straight to the tumor
Disease control OngoingThis study tests a drug called erdafitinib, placed directly into the bladder using a special delivery system, for people with non-muscle-invasive or muscle-invasive bladder cancer. The trial has four parts to find the best dose and check safety and effectiveness. About 235 partic…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase 1/2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New bladder cancer drug gets first human test
Disease control OngoingThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with non-muscle-invasive bladder cancer. The drug is injected directly into the tumor, sometimes with a laser. The main goal is to see if this approach is safe and feasible. About 55 pa…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase 1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New bladder cancer device offered to patients with no other options
Disease control ApprovedThis program gives patients with high-risk non-muscle invasive bladder cancer access to TAR-200 before it is officially approved. TAR-200 is a device placed into the bladder that releases medication over time. It is for patients who have tried all other treatments and cannot join…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Urine test may spare bladder cancer patients from frequent scopes
Diagnosis OngoingThis study is testing a urine test called BladMetrix to see if it can detect bladder cancer returning after surgery. 500 adults with non-muscle invasive bladder cancer will provide urine samples during routine follow-up visits over 2 years. The test's accuracy will be compared to…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC